Cargando…
Intensive Infection Control at a Canadian Tertiary Allergy and Clinical Immunology Clinic during COVID-19 to Provide Crucial Services
Autores principales: | Valois, Jodi, Pham, Hoang, Lanoue, Derek, Olynych, Tim, Yang, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849547/ http://dx.doi.org/10.1016/j.jaci.2020.12.574 |
Ejemplares similares
-
Proceedings of the Canadian society of allergy and clinical immunology annual scientific meeting 2015
por: Côté, Marie-Ève, et al.
Publicado: (2016) -
Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016
por: Alsayegh, Mohammad A., et al.
Publicado: (2017) -
Canadian Allergy, Asthma and Immunology Foundation
Publicado: (2005) -
Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
por: Cameron, Jodi, et al.
Publicado: (2014) -
Proceedings of the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2017
Publicado: (2018)